Blair William & Co. IL Sells 51,038 Shares of Dynavax Technologies Corporation $DVAX
35,615 Shares in Dynavax Technologies Corporation $DVAX Acquired by AXQ Capital LP
Ciena Set to Join S&P 500; Arrowhead Pharmaceuticals to Join S&P MidCap 400; ADT and OneSpaWorld Holdings to Join S&P SmallCap 600
AlphaQuest LLC Boosts Stock Position in Dynavax Technologies Corporation $DVAX
Dynavax President and COO Sells 114,000 Shares on Sanofi Acquisition News
Dynavax Technologies Corporation (NASDAQ:DVAX) Receives Average Rating of “Hold” from Brokerages
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger—DVAX, FONR, DBRG, and ONTF
Dynavax Technologies Corporation $DVAX Shares Sold by Chicago Capital LLC
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Dynavax Technologies Corporation (NASDAQ: DVAX)
Dynavax Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Dynavax Technologies Corporation - DVAX
Halper Sadeh LLC Encourages DVAX, CWAN, DBRG Shareholders to Contact the Firm to Discuss Their Rights
CORRECTING and REPLACING Dynavax Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Dynavax Technologies Corporation - DVAX
Dynavax Technologies (NASDAQ:DVAX) COO David Novack Sells 30,000 Shares
Dynavax Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Dynavax Technologies Corporation - DVAX
Shareholder Alert: The Ademi Firm investigates whether DigitalBridge Group, Inc. is obtaining a Fair Price for its Public Shareholders
Exchange Traded Concepts LLC Has $2 Million Stake in Dynavax Technologies Corporation $DVAX
Nvidia, Sobr Safe And 3 Stocks To Watch Heading Into Friday
Dynavax Technologies (DVAX) Shares Are Trending Overnight — Here's Why
Why Dynavax Stock Soared Today
Sanofi to Acquire Dynavax, Expanding Vaccine Portfolio
Dynavax Technologies Stock Soars on Buyout Buzz
Shareholder Alert: The Ademi Firm investigates whether Dynavax Technologies Corporation is obtaining a Fair Price for its Public Shareholders
Shares of Dynamax Are Up Nearly 40% Today. Here's Why The Stock Is Flying
Sanofi to acquire Dynavax in $2.2B Deal to boost adult vaccines
Stock Futures Stifled Ahead of Shortened Trading
Biggest Mover Wednesday: Dynavax Stock Soars on $2.2 billion Acquisition Deal
Sanofi to acquire Dynavax for $2.2B, sending shares higher by 37%
Sanofi To Buy Vaccine Maker Dynavax for $2.2 Billion
Sanofi Makes $2.2 Billion Bet On Adult Vaccines With Dynavax Buy
DVAX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Dynavax Technologies Corporation is Fair to Shareholders
Sanofi to acquire US biotech Dynavax for $2.2 billion
Sanofi to Buy Vaccine Maker Dynavax in $2.2 Billion Deal
Sanofi to Acquire Dynavax, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline
Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline
Dynavax Technologies (NASDAQ:DVAX) vs. Amgen (NASDAQ:AMGN) Head to Head Survey
Geode Capital Management LLC Sells 377,048 Shares of Dynavax Technologies Corporation $DVAX
Dynavax Technologies Corporation (NASDAQ:DVAX) Receives $24.33 Average Price Target from Analysts
Dynavax to Participate at the 8th Annual Evercore Healthcare Conference
Campbell & CO Investment Adviser LLC Sells 24,624 Shares of Dynavax Technologies Corporation $DVAX
Dynavax Technologies Corporation (DVAX) Q3 2025 Earnings Call Transcript
Dynavax Technologies (DVAX) Surpasses Q3 Earnings Estimates
Dynavax Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program
Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral COVID-19 Vaccine Program
139,227 Shares in Dynavax Technologies Corporation $DVAX Purchased by Y Intercept Hong Kong Ltd
Dynavax to Report Third Quarter 2025 Financial Results and Host Conference Call on November 5, 2025
Dynavax Presents Positive Topline Data from Part 1 of Phase 1/2 Trial for Shingles Vaccine Candidate at IDWeek 2025 and Announces Initiation of Part 2 of Trial
3 Of My Favorite Biotech Stocks Under $10
Dynavax to Participate in the 2025 Wells Fargo Healthcare Conference
Dynavax's shingles vaccine shows similar immune response to GSK's shot in study